Tag Archives: takes

Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

MVNHS© takes a hit

Science: How does it work? “NHS sued for failure to help transgender patients with fertility“ No kidding? This time, it’s really not the Much Vaunted National Health Service© at fault, though. The rocket surgeons at Britain’s Equality and Human Rights Commission is suing the Service because it doesn’t pay for the (non-existent) fertility rights of… Read More »